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Osteoarthritis (OA) in obese individuals is often attributed to joint loading. However, a subtype of OA,
Metabolic OA, may be due to obesity-related intrinsic factors but remains to be evaluated experimentally
against a known OA progression model.
Objective: To evaluate if obesity contributes to OA onset using a high fat/high sucrose diet-induced
obesity (DIO) model with anterior cruciate ligament-transected rats (ACL-X).
Methods: Sprague Dawley rats (n ¼ 33) consumed high fat/high sucrose or chow diets for 12 weeks, were
randomized to one of three groups: a unilateral ACL-X group, sham surgery group, or naïve non-surgical
group. These animals were followed for an additional 16 weeks. At sacriﬁce, body composition, knee joint
Modiﬁed Mankin scores, and 27 serum and synovial ﬂuid cytokines and adipokines were measured.
Results: Experimental limbs of obese ACL-X, obese Sham, and lean ACL-X animals had similar Modiﬁed
Mankin scores that were greater than those obtained from lean Sham and naïve animals. Obese
contralateral limbs had similar OA damage as ACL-X and Sham limbs of obese and ACL-X limbs of lean
animals. Obese contralateral limb Modiﬁed Mankin scores had a strong correlation (r ¼ 0.75, P < 0.001)
with body fat percentage. Serum leptin and synovial ﬂuid IP10/CXCL10 best described Modiﬁed Mankin
scores in contralateral limbs of obese animals.
Conclusions: Mechanical factors produced OA damage in experimental limbs, as expected. Interestingly,
OA damage in obese contralateral limbs was similar to mechanically perturbed limbs, suggesting that
obesity may induce OA in a non-mechanical manner.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Traditionally, Osteoarthritis (OA) has been thought to be due to
the mechanical wear and tear of joints1,2. Obesity has been asso-
ciated with OA due to increased mass and therefore increased joint
load3,4. However, obese individuals were found to develop OA in
hands 5e8 times more frequently than non-obese people5. Since
loading of joints in the hand is independent of body mass, this
result suggests that factors other than loading caused by body mass
may cause OA in obese individuals. Recently, a subtype of OA, called
metabolic OA, has been identiﬁed as a disorder that displays aW. Herzog, 2500 University
Fax: 1-403-220-2070.
Collins), reimer@ucalgary.ca
rattan), leonard@ucalgary.ca
ternational. Published by Elsevier Lunique OA trajectory that is potentially independent from the
biomechanical contribution to joint load6.
Due to the multi-factorial nature of OA, it is challenging to
identify early onset of the disease. One of the animal models
developed to induce OA reliably is a Post-Traumatic Arthritis (PTA)
model7. The probability of PTA after a ligament injury is greater
than 50%8. One of the best validated and widely accepted models of
PTA is anterior cruciate ligament transection (ACL-X), which creates
instability in knee joints9.
In order to understandmetabolic OA, diet-induced obesity (DIO)
models must be compared to validated models of OA. There is an
evolving body of work aimed at understanding the effects of DIO on
OA. In a genetic obesity murine model, obesity was associated with
elevated OA progression, loss of muscle function, and increased
blood serum levels of speciﬁc cytokines10. In another study, DIO
was superimposed on an intra-articular fracture in mice. Only
fractured knee joints from animals in the obese group had moretd. All rights reserved.
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also demonstrated increased levels of selected serum cytokines,
and decreased adiponectin concentrations11. Additional studies
also found that DIO affects the rate of progression of OA, but not
onset12,13.
Obese patients often present with knee OA without a history of
intra-articular knee injury6. Furthermore, diets used in previous
animal studies may not be the best model of a typical human
western-type diet, because the high percentage of fat (>50% kcal
from fat) could be considered extreme14. Rather, it is thought that
the obesity epidemic in North America is driven by processed foods
consisting of high fats and simple carbohydrates15. Additionally, in
rodent obesity OA models, synovial ﬂuid inﬂammatory proﬁles
have not been determined for comparison between local and sys-
temic inﬂammatory environments.
Therefore, the purpose of this study was to develop a pre-
clinical metabolic model of OA using a high fat/high sucrose (DIO)
diet and ACL-X in an attempt to understand local and systemic
inﬂammatory mechanisms that potentially link obesity to joint
damage. Experimental and contralateral limbs of diet-induced
obese and lean animals were evaluated at 16 weeks post-surgery
in the presence of ACL-X in male Sprague Dawley rats. We hy-
pothesized that animals exposed to DIOhave a higher incidence of
OA onset in contralateral control limbs, and in the ACL-X limbs
compared to lean animals.
Methods
Animals
Thirty-three male, 8e12-week old Sprague Dawley rats were
housed individually on a 12 h dark/light cycle. Animals were ran-
domized to either the high fat/high sucrose diet-induced obesity
group (DIO, 40% of total energy as fat, 45% of total energy as sucrose,
n¼ 21, customDiet #102412, Dyets, Inc), or the standard chow low
fat diet group (LFD, 12% fat, n¼ 12, Lab Diet 5001) for a 28-week ad
libitum feeding intervention11,16,17. The high fat/high sucrose diet
consisted of (g/100 g): casein (20.0), sucrose (49.9), soybean oil
(10.0), lard (10.0), Alphacel (5.0), AIN-93M mineral mix (3.5), AIN-
93 vitamin mix (1.0), DL-methionine (0.3), and choline bitartrate
(0.25). The energy density of the high fat/high sucrose diet is
4.6 kcal/g and 3.34 kcal/g for chow. All experiments were approved
by the University of Calgary's Animal Care Committee.
Surgery
After a 12-week obesity induction period, the two groups were
randomized into an ACL-X with DIO (n ¼ 10), a LFD (n ¼ 4), a sham
surgery group with DIO (n ¼ 5), a LFD (n ¼ 3), a DIO naïve control
group (n ¼ 6), and a LFD naïve control group (n ¼ 5). ACL-X and
sham surgeries were performed unilaterally in a randomly assigned
hind limb. The ACL was cut mid-substance using a surgical hook18.
An anterior drawer test was conducted to conﬁrm ACL transection,
and ACL transection was conﬁrmed at sacriﬁce. Sham surgery was
conducted by entering the joint via a lateral incision, spraying the
joint with saline, and closing the joint capsule. Contralateral limbs
served as non-operated controls. Six DIO and Five LFD age-matched
animals were analyzed as non-operated controls.
Body composition
At 16-weeks post-surgery (36e40 weeks old), animals were
sacriﬁced by barbiturate overdose (Euthanyl®, MTC Animal Health
Inc., Cambridge, Ontario, Canada). Immediately after sacriﬁce, body
composition was measured using Dual Energy X-rayAbsorptiometry with software for small animal analysis (Hologic
QDR 4500; Hologic, Bedford, MA). Body fat percentage was calcu-
lated as the value of body fat divided by total body mass.
Preparation of knee joints
Joints were harvested by cutting the femur and tibia/ﬁbula 2 cm
above and below the joint line. Excess muscle was trimmed away
and joints were ﬁxed in a 10% neutral buffered formalin solution
(Fisher Scientiﬁc Company, Ottawa, Ontario, Canada) for 10 days at
room temperature. Joints were then decalciﬁed for 2 weeks at room
temperature, using Cal-Ex II solution (10% formic acid in formal-
dehyde, Fisher Scientiﬁc). The solution was changed daily and the
end of decalciﬁcationwas determined by chemical testing with a 5%
ammonium oxalate solution (Fisher Scientiﬁc) until no precipitate
was observed for 5 days. The intact joints were processed in an
automatic parafﬁn processor (Leica TP 1020, Leica Microsystems
Inc., Concord, Ontario, Canada). Samples were dehydrated in a
graded series of alcohols, cleared in xylene, and inﬁltrated with
Paraplast® Plus wax (Fisher Scientiﬁc). Whole knee joints were
embedded in parafﬁn wax and stored at room temperature until
sectioning.
Serial, sagittal plane sections of 8 mm thickness were obtained
using a Leica RM 2165 microtome. Sections were mounted onto
Super Frost plus slides (Fisher Scientiﬁc) and allowed to dry at 40C
for 4 days. Sampling was done approximately every 80 mm. Alter-
nate slides were stained sequentially with haematoxylin, fast green
and safranin-O stains (Fisher Scientiﬁc) using an auto stainer (Leica
ST 5010). Sections were then dehydrated in a graded series of al-
cohols, cleared in xylene, and mounted with cytoseal 60 mounting
media (Richard Allan) using an auto cover slipper (Leica CV 5030).
Slides were dried at room temperature for several days before be-
ing evaluated using a light microscope (Zeiss Axiostar plus, Carl
Zeiss Inc., Toronto, Ontario, Canada). Images were digitized using a
Zeiss Axiocam® Icc 5 camera and analyzed using the Zen 2011 Zeiss
imaging system. Sections were examined under 10 and 25 ob-
jectives and scored for OA degeneration using a Modiﬁed Mankin
scoring system19.
Osteoarthritis scoring
Joints were scored by two independent, blinded observers. A
Modiﬁed Mankin Score was developed, where ﬁve areas were
scored on the standard 14-point Mankin scale19: the medial and
lateral tibial plateau, the medial and lateral femoral condyle, and
the patella. Subchondral bone and synovium were then assessed
using a ﬁve and four point criteria, adapted from the rat-speciﬁc
OARSI metric20. The ﬁnal Modiﬁed Mankin score was determined
by adding the ﬁve site-speciﬁc Mankin scores to the two corre-
sponding OARSI scores19e21.
Cytokine, growth factor, and adipokine measurements
Animals were fasted for 12 h prior to sacriﬁce and blood
collected immediately following sacriﬁce via cardiac puncture22.
Synovial ﬂuid was collected shortly after sacriﬁce using the
Whatman chromatography paper method23. Samples were diluted
1:60, spun at 13,500 revolutions per minute, and stored at 20C
overnight. Samples were aliquoted 24 h later and stored at 80C
until analysis23.
Twenty seven serum and synovial ﬂuid cytokines and adipo-
kines were quantiﬁed using a Rat 27 Multiplex Discovery Assay
with Luminex®xMAP technology (Eotaxin, EGF, Fractalkine, IL-1a,
IL-1 b, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12(p70), IL-13, IL-17A, IL-18, IP-
10/CXCL10, GRO/KC, IFN-g, TNF-a, G-CSF, GM-CSF, MCP-1, leptin,
Fig. 1. Relative body fat (a, %), Body mass (b, g), absolute body fat (b, g), and
demonstrated by group: Obese anterior cruciate ligament transected (DIO ACL-X,
n ¼ 10), Obese Sham (DIO Sham, n ¼ 5), Obese Naïve non-operated control (DIO
Naïve, n ¼ 6), Lean chow ACL-X (LFD ACL-X, n ¼ 4), Lean chow sham (LFD Sham, n ¼ 3),
Lean chow non-operated naïve (n ¼ 5). Regardless of surgery (ACL-X or sham),
DIO animals had more body fat and body mass when compared to lean (LFD) animals
at sacriﬁce (16- weeks post-surgery, 28- weeks post obesity intervention, P < 0.001).
Data are shown as means and 95% conﬁdence intervals (CI) of the mean, and * in-
dicates signiﬁcant differences between DIO and LFD for body fat outcomes, and #
indicates signiﬁcant differences between DIO and LFD body mass (P < 0.05).
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(VEGF), Eve Technologies, Calgary, AB). Urea was evaluated in
duplicate in serum and synovial ﬂuid using an ELISA (Eve Tech-
nologies, Calgary, AB)24,25 to adjust for volumetric differences in
synovial ﬂuid concentration. Blood glucose was assessed using a
Trinder assay (Sigma, Oakville, ON, Canada).
Longitudinal kinetics
Twelve weeks post obesity induction, 1 week post-surgery, 8
weeks post-surgery, and 16-weeks post-surgery, ground reaction
forces were measured during locomotion using a 1-m custom
runway with two embedded side-by-side 7.5  30 cm, 3-
dimensional force plates (Bertec, Columbus, OH, 500 Hz). A high-
speed camera (200 Hz) conﬁrmed speed and ground contact. Ani-
mals were acclimatized to the runway prior to measurements.
Successful trials included a uniform speed and a single hind limb
contact on each plate. A minimum of three successful trials was
needed for inclusion into the analysis.
Statistical analysis
Wilcoxon rank sum tests were used to evaluate paired between-
limb outcomes within each group. KruskaleWallis tests were used
to evaluate between group outcomes relative to naïve age-matched
controls. Friedman's test was used to evaluate longitudinal
repeated measures kinetic data. Linear regression was used to
evaluate each analyte with body fat to predict Modiﬁed Mankin
Scores. Spearman correlations were used to associate Modiﬁed
Mankin scores with cytokines by diet (IBM SPSS Statistics 20,
a ¼ 0.05).
Results
Body composition and joint damage
DIO diet group animals had a higher percent body fat, absolute
amount of body fat, and body mass than animals in the LFD group
(P < 0.001, Fig. 1). DIO animals had a 68.3 ± 7.0% increase in body
mass, whereas LFD animals had a 31.4 ± 3.0% in body mass over the
study period.
There were no differences between limbs in either the number
of lesions or the Modiﬁed Mankin Scores between DIO ACL-X and
DIO Sham groups (Fig. 2). Modiﬁed Mankin scores were similar in
DIO ACL-X, DIO Sham, DIO naive, and LFD ACL-X group animals, but
their values were higher than those measured in LFD Sham and LFD
naive control limbs (P < 0.01). The number of cartilage lesions was
similar in the experimental limbs of DIO ACL-X, DIO Sham, and LFD
ACL-X group animals. Modiﬁed Mankin scores and the number of
lesions were higher in the contralateral knees of DIO ACL-X than in
LFD contralateral limbs, independent of surgery (P < 0.01, Fig. 3).
Synovial ﬂuid, cytokines, and adipokines
No detectable statistical differences were found between ACL-X
and Sham operated experimental or contralateral limbs in either
dietary group for any of the 27 outcome measures. Therefore, sy-
novial ﬂuid analyte data were pooled into the following groups:
DIO experimental, DIO contralateral, LFD experimental, and LFD
contralateral. Four analytes were increased in DIO compared to LFD
animals (Table I), but there were no differences in analytes by
surgery. Synovial ﬂuid leptin, IL-1a and IP10/CXCL10 were higher in
DIO compared to LFD animals (P < 0.05), while VEGF trended to be
higher in DIO animals, but was not signiﬁcant (P > 0.05). Valuesmeasured for the remaining analytes are provided in
Supplementary Table 1.
Serum cytokines and adipokines
DIO animals had higher blood glucose (7.5, 6.5e8.5 mmol/L)
than LFD animals (6.0, 7.0e5.1,mmol/L, P ¼ 0.046). Three synovial
ﬂuid analytes were higher in DIO animals compared to LFD animals,
and two of those were also higher in the serum of the DIO
animals: leptin (P ¼ 0.001) and IP10/CXCL10 (P ¼ 0.008, Table I).
Serum VEGF was also higher in DIO animals compared to LFD
animals (P ¼ 0.047).
AB
Fig. 2. (A) Modiﬁed Mankin composite score was measured by adding the 14-point
Mankin score from 5-sites (medial tibial plateau, medial femoral condyle, lateral
tibial plateau, lateral femoral condyle, and patella) and the 4- and 5- point Rat OARSI
score for synovium and bone, respectively. Data are demonstrated by group: Obese
anterior cruciate ligament transected (DIO ACL-X, n ¼ 10), Obese Sham (DIO Sham,
n ¼ 5), Obese Naïve non-operated control (DIO Naïve, n ¼ 6), Lean chow ACL-X (LFD
ACL-X, n ¼ 4), Lean chow sham (LFD Sham, n ¼ 3), Lean chow non-operated naïve
(n ¼ 5). Experimental operative limbs are shown in black and contralateral non-
operative limbs are shown in grey. Data are shown as means and 95% CI. P-values
were calculated between each group and the lean naïve control group, and signiﬁcant
differences are indicated by y (P < 0.05). When compared to LFD naïve non-operative
age and sex matched control limbs, All DIO experimental limbs, DIO ACL-X and DIO
SHAM, had similar damage to LFD Anterior Cruciate Ligament Transected (ACL-X)
experimental limbs, but greater damage than the LFD SHAM experimental limbs and
LFD naïve control limbs (P < 0.01). Although non-surgical, DIO ACL-X and SHAM
contralateral limbs had similar damage to DIO ACL-X, DIO SHAM, and LFD ACL-X
experimental limbs, which was greater than LFD ACL-X contralateral limbs, both LFD
SHAM limbs, and LFD naïve control limbs (P < 0.01). (B): Number of lesions by limb by
group. P-values were calculated between each group and the lean naïve control group,
and signiﬁcant differences are indicated by y (P < 0.05). Experimental operative limbs
are shown in black and contralateral non-operative limbs are shown in grey. The
number of cartilage lesions was similar in the experimental limbs of DIO ACL-X, DIO
Sham, and LFD ACL-X group animals. The number of lesions were higher in the
contralateral knees of DIO ACL-X and DIO Sham group animals than in LFD ACL-X and
LFD Sham group animals (P < 0.01). Data are shown as means and 95% CIs of the mean.
Fig. 3. Sagittal plane histological slides cut at 8 mm. Representative contralateral non-
operative limbs from LFD ACL-X group (top, Modiﬁed Mankin score of 11) and DIO ACL-
X group (bottom, Modiﬁed Mankin score of 29).
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Modiﬁed Mankin scores and body fat percentage were posi-
tively related in the experimental (r ¼ 0.60 P ¼ 0.004) and
contralateral limbs (r ¼ 0.75 P < 0.001) of all DIO animals. Body
mass was not signiﬁcantly related to Modiﬁed Mankin scores in the
contralateral (r ¼ 0.40 P ¼ 0.07) or the experimental limbs
(P ¼ 0.215). Body mass and percent body fat were not related in
either limb of LFD animals.
Increases in contralateral limb IP10/CXCL10 were associated
with increases in percent body fat (r ¼ 0.39, P ¼ 0.043), and
Modiﬁed Mankin scores (r ¼ 0.65, P < 0.001) in DIO animals. Also,
synovial ﬂuid IP10/CXCL10 was positively related with synovial
ﬂuid leptin (r ¼ 0.95, P < 0.001), synovial ﬂuid IL-1a (r ¼ 0.85,
P < 0.001), and synovial ﬂuid VEGF (r ¼ 0.96, P < 0.001).
Serum leptin and serum IP10/CXCL10 were positively correlated
with percent body fat (r ¼ 0.47, P ¼ 0.005 and r ¼ 0.28 P ¼ 0.044,
respectively). Serum leptin was also positively associated with
Modiﬁed Mankin scores in the contralateral limbs of DIO animals
(r ¼ 0.40, P ¼ 0.001), synovial ﬂuid leptin from both limbs (r ¼ 0.47,
P ¼ 0.013), and synovial ﬂuid IP10/CXCL10 (r ¼ 0.51 P ¼ 0.004), IL-
1a (r ¼ 0.48 P ¼ 0.006), and VEGF (r ¼ 0.40 P ¼ 0.015) from both
limbs. There was no relationship between any of the analytes and
the percent body fat or Modiﬁed Mankin scores in LFD group
animals.
Table I
Summary of cytokine, adipokine, and growth factor protein levels that were increased in either synovial ﬂuid and serum of obese animals. Data are presented for all surgical
groups pooled by diet: Obese (DIO, n ¼ 15) and Lean (LFD, n ¼ 7). Synovial ﬂuid biomarkers differed by diet (P < 0.05), but not by surgery or between contralateral and
experimental limbs. Therefore, synovial ﬂuid protein levels are presented as obese (DIO) and lean chow (LFD) groups by experimental and contralateral non-surgical limb. P-
values were calculated between DIO and LFD experimental limbs, DIO and LFD non-surgical contralateral limbs, and DIO and LFD serum protein levels. Data are presented as
means and 95% CIs of the mean, signiﬁcant P-values between DIO and LFD animals are bolded. Synovial ﬂuid leptin, IL-1a and IP10/CXCL10 were higher in DIO high fat high
sucrose animals compared to LFD group animals (P < 0.05). Synovial ﬂuid VEGF trended to be higher in DIO animals, but was not signiﬁcant (P > 0.05). Of the three synovial
ﬂuid analytes that were higher in DIO animals compared to LFD animals, twowere also higher in the serum of the DIO animals: leptin (P < 0.001) and IP10/CXCL10 (P¼ 0.005).
Additionally, serum VEGF was higher in DIO animals compared to LFD animals (P ¼ 0.047). Data are shown as means and 95% CIs of the mean
Analyte DIO Exp (ng/mL)
Mean (CI) n ¼ 15
LFD Exp (ng/mL)
Mean (CI) n ¼ 7
P-value DIO Con (ng/mL)
Mean (CI) n ¼ 15
LFD Con (ng/mL)
Mean (CI) n ¼ 7
P-value DIO Serum (ng/mL)
Mean (CI) n ¼ 15
LFD Serum (ng/mL)
Mean (CI) n ¼ 7
P-value
IL-1a 76.4 (18.1e134.7) 11.8 (4.5e18.9) 0.022 25.5 (12.2e38.9) 8.8 (4.5e13.1) 0.001 0.2 (0.1e0.2) 0.2 (0.0e0.3) NS
IP-10 25.1 (0.3e49.7) 4.9 (0.0e9.8) 0.044 6.7 (3.0e10.4) 3.0 (1.5e4.6) 0.045 0.2 (0.2e0.3) 0.1 (0.1e0.2) 0.005
Leptin 3250.4 (556.8e7057.6) 200.0 (72.0e328.0) 0.002 1290.1 (331.9e2248.4) 141.0 (79.0e202.2) <0.001 37.1 (28.7e45.5) 13.7 (7.4e20.0) <0.001
VEGF 58.2 (0e136.7) 18.2 (0e51.2) 0.18 22.2 (0.4e46.1) 4.5 (2.4e6.6) 0.06 0.08 (0.07e0.09) 0.06 (0.04e0.09) 0.047
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Linear regression modeling was used to evaluate the combined
predictive value of signiﬁcantly associated outcomes with Modiﬁed
Mankin Scores. Contralateral limb Synovial ﬂuid IP10/CXCL10 and
percent body fat were signiﬁcant predictors of joint damage in the
contralateral limbs of DIO and LFD animals (r2 ¼ 0.70, P < 0.001,
Table II). When body fat percentage and leptin are evaluated in
contralateral limbs of all animals, a smaller degree of variation in
the Modiﬁed Mankin scores is explained (r2 ¼ 0.54 P < 0.001).
Contralateral limb IL-1a and VEGFwere not associatedwith percent
body fat or ModiﬁedMankin scores. Serum leptin and synovial ﬂuid
IP10 (r2 ¼ 0.75, P < 0.001) explained more of the variance in
Modiﬁed Mankin scores in contralateral limbs than serum IP10/
CXCL10 and synovial ﬂuid IP10/CXCL10 (r2¼ 0.63, P < 0.001), serum
leptin and synovial ﬂuid leptin (r2 ¼ 0.55, P < 0.001), or serum
leptin alone (r2 ¼ 0.37, P ¼ 0.001).
Longitudinal kinetic analysis
Only 3 DIO ACL-X, 3 LFD ACL-X, 3 DIO SHAM, and 3 LFD Sham
animals met all inclusion criteria. LFD ACL-X animals unloaded the
experimental limb most, 1 week post-surgery, whereas LFD Sham
animals did not demonstrate decreased experimental limb loading
[Fig. 4(a)]. DIO experimental limbs, regardless of surgery, were
unloaded most at week 8 [Fig. 4(b)] and continued to be unloaded
at 16 weeks compared with DIO contralateral limbs. All contralat-
eral limb normalized and absolute peak vertical ground reaction
forces measured, regardless of diet or surgery, were statistically
similar across all time-points (P > 0.05).
Discussion
Obesity is strongly associated with OA. A subtype of OA, meta-
bolic OA, has been suggested to occur independently of the me-
chanical contribution of obesity to joint load6. We evaluated thisTable II
Summary of outputs from linear regression modeling estimating ModiﬁedMankin Scores
analytes are included, non-surgical contralateral limb values were used. В-coefﬁcients an
CI of the mean. R-squared (r2), F-statistics, standard error of the estimate, and P-value of
Factors included r2 b F-stati
Serum systemic
marker
Synovial ﬂuid
marker
Mean CI lower
limit
CI upper
limit
Leptin IP-10 0.75 4.66 0.36 9.70 32.3
Body fat IP-10 0.73 0.231 8.12 8.59 25.7
IP-10 IP-10 0.63 2.14 8.30 12.7 18.5
Body fat Leptin 0.53 0.74 8.72 10.2 12.2
Leptin Leptin 0.55 6.76 0.74 12.8 13.1
Leptin e 0.37 7.82 0.15 15.5 13.5potential subtype in a rat model by superimposing DIO on ACL-X
surgery.
DIO has been observed to increase the severity of OA in intra-
articular fractured limbs of mice over a 20 and 24 week
period11,13. However, in a rabbit model of varus bowing, there was
no difference in the experimental limbs of DIO compared with LFD
group animals over 38 weeks12. Our results show a similar degree
of knee joint damage in DIO ACL-X and LFD ACL-X animals sug-
gesting that DIO does not affect animals over the period studied
here.
Among all mechanical models of OA, ACL-X is considered the
most severe26. Therefore, it is possible that mechanical drivers from
ACL-X may over-ride the OA processes originating from metabolic
factors. Some of the experimental limbs reached end-stage OA
(Mankin score 7/14) in one or more of the evaluated regions;
therefore differences in OA may have occurred prior to sacriﬁce19.
Future work should evaluate shorter time periods to determine the
combined effects of DIO and ACL-X on the rate of OA progression.
The similarity in knee joint damage in DIO Sham and DIO ACL-X
was not expected, since previous studies found that ACL-X
consistently produced greater damage than sham in-
terventions11,12,21. DIO animals may exhibit an immune response
that is activated upon surgery given the low-level of systemic
inﬂammation27. Generally, sham surgery serves as a surgical con-
trol and is not associated with OA damage, which is consistent with
our ﬁndings in LFD sham animals28. Therefore, there appears to be
an obesity-driven response causing increased damage in DIO Sham
compared to LFD Sham knees.
We hypothesized that obesity affects OA onset. All DIO non-
surgical contralateral limbs had the same Modiﬁed Mankin scores
as the DIO surgical limbs, regardless of ACL-X or sham surgery. For
DIO animals, body fat explained the majority of the variance in
Modiﬁed Mankin scores from both limbs, whereas body mass and
Modiﬁed Mankin Scores did not have a signiﬁcant statistical asso-
ciation in either limb. These data suggest that OA damage is not
simply caused by over-loading of joints from increased body mass.across all surgical animals: obese (DIO, n¼ 15) and lean (n¼ 7). Where synovial ﬂuid
d Predicted Modiﬁed Mankin Scores for each model are presented as mean and 95%
the model are also provided
stic Standard error
of estimate
P-value of
model
Predicted Modiﬁed Mankin score
Mean CI lower limit CI upper limit
5.35 <0.001 19.6 15.5 24.3
5.82 <0.001 19.6 15.5 24.3
6.53 <0.001 19.6 15.4 24.5
6.46 <0.001 18.5 14.8 22.4
6.32 <0.001 18.5 14.7 22.5
8.44 0.001 19.6 15.5 24.3
Fig. 4. Peak vertical ground reaction force normalized to body weight for lean chow
animals (LFD, panel A) and obese (DIO, panel B) animals. Data are presented as LFD
anterior cruciate ligament transected (ACL-X, n ¼ 3), LFD sham surgery (n ¼ 3), DIO
ACL-X (n ¼ 3), and DIO sham (n ¼ 3) over four time points throughout the duration of
the study: pre-surgery, 1 week post-surgery, 8 weeks post-surgery, and 16 weeks post-
surgery. Peak vertical ground reaction forces are plotted for both surgical (circle) and
non-surgical contralateral (square) limbs. ACL-X animals are shown in black, and sham
animals are shown in grey. Data are shown as means and 95% CIs of the mean. P-values
were calculated at all time points between limbs, and z indicates a signiﬁcant differ-
ence in load sustained between Sham experimental and contralateral limbs, and #
demonstrates a difference between ACL-X experimental and contralateral limbs
(P < 0.05). LFD ACL-X animals demonstrated decreased loading in the experimental
limb at 1 week post-surgery, but that difference was resolved over time such that load
bearing was approximately equal at 8 and 16 weeks post-surgery. LFD Sham animals
demonstrated similar side to side loading at all time points. In contrast, regardless of
ACL-X or Sham surgery, DIO animals demonstrated similar loading between experi-
mental and contralateral limbs at baseline and 1 week post-surgery. However, all DIO
animals demonstrated decreased loading at 8 weeks that persisted at 16 weeks post-
surgery, despite similar Modiﬁed Mankin Scores in experimental and contralateral DIO
non-surgical limbs.
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animal joints has not been widely explored and remain to be
clariﬁed29.
The intervention diet used in this study incorporated higher fat
energy and higher simple carbohydrate energy compared to the
standard diet. Previous animal work evaluating obesity and OA
utilized either monogenic models of obesity or high fat diets10e13.
However, the liver has been shown to be differentially affected
following a high fat or high sucrose diets30, and speciﬁc macro-
nutrients may affect leptin resistance differently independent of
body fat31. We suggest that although the resultant obesity may be
similar, the intrinsic changes due to high fat/high sucrose diet may
affect OA differently compared with an exclusively high fat diet.Speciﬁcally, advanced glycation end-products, harmful com-
pounds thought to contribute to degenerative disease, are associ-
ated with increased blood glucose, and have been implicated in the
pathogenesis of oxidative-based diseases such as type 2 diabetes
mellitus32. Through hyperglycemic pathways, oxidative stress and
advanced glycation end-products have also been suggested to
contribute to cartilage degradation6. Here, DIO animals had higher
blood glucose concentrations compared to LFD animals. By
inducing obesity through a high fat/high sucrose diet, we speculate
that this study may have replicated a more clinically relevant
metabolic dysregulation33. However, to our knowledge, the relative
contribution of high fat and high sucrose to advanced glycation end
products remains unknown.
Neither body fat percentage nor body mass correlated with the
Modiﬁed Mankin scores in LFD animals regardless of surgery,
possibly because of the homogeneity of body fat percentage and
bodymass in this group. However, despite being smaller and leaner,
LFD animals sustained similar damage due to ACL-X surgery as DIO
ACL-X, DIO Sham, and DIO contralateral limbs. OA in the experi-
mental limb of LFD ACL-X animals may be largely caused by
changes in joint loading conditions, whereas DIO Sham and
contralateral limb damage may be driven primarily by metabolic
factors.
To clarify the role of intrinsic factors related to obesity, 27 serum
and synovial ﬂuid inﬂammatory markers, cytokines, and hormones
were measured. Despite similar Modiﬁed Mankin scores, the local
(synovial ﬂuid) and systemic (serum) inﬂammatory cytokine con-
centrations differed between DIO and LFD animals. Furthermore,
increased concentrations of 2 of the 27 serum markers (serum
leptin and serum IP10/CXCL10) were signiﬁcantly correlated with
increased Modiﬁed Mankin scores in DIO animals. These markers
have previously been implicated in OA6,34,35. Three synovial ﬂuid
mediators were elevated in DIO compared to LFD animals: leptin,
IL-1a, IP10/CXCL10.
Systemic leptin is generally proportional to body fat36, and may
affect chondrocytes through NoSynthase-2, IGF-1, TGF-beta, IL-8
(GRO-KC), or synovial ﬁbroblasts through tMMPQ-1337,38. Systemic
leptin could be the initiator of the downward cascade of joint
degradation36. In a DIO murine model, 90% of the variance in pro-
teoglycan staining loss was explained by body fat percentage,
supporting a case for body composition and adipose-derived
catabolic cytokines in OA disease pathology10. In the present
study, there was a strong relationship between DIO contralateral
limb Modiﬁed Mankin score and body fat. It is possible that the
reduced variance explained in Modiﬁed Mankin Score by body fat
in our study is due to the confounding effect of ACL-X. Others have
shown that leptin deﬁcient mice gained weight but did not develop
OA39,40, which suggests that mass increase in the absence of leptin
signaling is not sufﬁcient to cause OA. In humans, the ratio of
plasma leptin and synovial ﬂuid leptin may be a marker of OA
severity41. In this study, synovial ﬂuid leptin was higher in all DIO
compared to LFD animals, regardless of limb and surgery.
Likely, an inﬂammatory mediator downstream of leptin is
involved in Metabolic OA39. IP10/CXCL10, a chemo-attractant for
monocytes and macrophages selectively activated by leptin, is
associated with angiogenesis, and increases in the numbers of
monocytes and macrophages in fat and muscle42. Obese OA pa-
tients have lower lean mass, decreased muscle strength, and a
relatively higher fat mass with low-level systemic inﬂammation, so
IP10/CXCL10 may provide insight into the link between muscle, fat,
and cartilage damage43. Together, serum leptin and synovial ﬂuid
IP10/CXCL10 may explain more variance in OA damage than serum
and synovial ﬂuid leptin.
Also, IP10/CXCL10 stimulates subchondral bone progenitors
in vitro, whichmay be onemechanism of joint damage inMet-OA42.
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have been reported to be lower than synovial ﬂuid IP10/CXCL10
concentrations in rheumatoid arthritis patients43. The synovial
ﬂuid in that study was not obtained exclusively from obese pa-
tients, so increases in IP10/CXCL10 may have been missed. In
rheumatoid arthritis, IP10/CXCL10 is expressed by inﬁltrating
macrophages and the synovium, leading to osteoclastogenesis44. It
is possible that 1P10/CXCL10 has been missed in the past due to a
lack of OA subtyping masking increases in IP10/CXCL10. However,
the strong associations here warrant future investigation into the
role of IP10/CXCL10 and metabolic OA.
VEGF has also been shown to induce IP10/CXCL1045. Moreover,
serum VEGF, a marker for angiogenesis and critical for adipose
signaling, has been associated with inﬂammatory arthritis46,47.
Here, we observed increased serum VEGF in DIO animals compared
to LFD. Plasma and synovial ﬂuid VEGF has been shown to correlate
positively with radiographic knee OA severity, but a non-signiﬁcant
trend toward increased synovial ﬂuid VEGF in DIO animals was
observed here48.
In agreement with previous work, there was no difference be-
tween LFD and DIO in serum IL-1a, IL-1b, IL-4, IL-10, TNF-a, or IL-6
in this study49. However, we observed increases in synovial ﬂuid IL-
1 a in DIO animals compared to LFD animals, which is thought to
contribute to matrix degradation and cartilage catabolism. In-
creases in synovial ﬂuid IL-1a have been shown to be associated
with mild and moderate OA50. We did not ﬁnd a signiﬁcant asso-
ciation between OA damage and IL-1a.
Although the mechanical data presented here are limited, we
believe these data suggest a non-mechanical driver for metabolic
OA. Previously, we and others demonstrated a side to side loading
disparity after ACL-X, that is restored over time in cats18. Here, LFD
animals follow that paradigm. Load was reduced in all DIO exper-
imental limbs at 8 and 16 weeks compared to DIO contralateral
limbs, regardless of ACL-X or sham surgery. This ﬁnding is of in-
terest because the similar average Mankin scores were observed in
both experimental and contralateral DIO limbs at 28 weeks.
Therefore, we suggest that these preliminary kinetic data support
the notion that different drivers (biological in contralateral, me-
chanical in experimental) may affect OA, as these limbswith similar
damage are loaded differently. However, as joints were not scored
for OA at each time point, we cannot conclusively say that the joint
damage was similar throughout the duration of the study. Differ-
ences in the time-course of experimental limb unloadingmay affect
OA progression. These inclusion criteria may delineate a subset of
animals that demonstrate this pattern. This phenomenon warrants
further investigation.
This cross-sectional study does not evaluate OA progression, or
structural damage due to DIO and surgery over time, which
is critical to our understanding of the mechanism of metabolic OA.
Future work elucidating mechanisms of Met-OA should be con-
ducted over several time points, and involve serial time-course
measurements, to characterize the effects of high fat/high sucrose
DIO on OA progression.
Conclusion
From the results of this study, we conclude that obesity from a
high fat/high sucrose diet is an independent risk factor for the onset
of OA in the rat ACL-X knee. These phenomena may be clariﬁed in
future work by investigating the role of advanced glycation end-
products from the enhanced dyslipidemia and hyperglycemia
from the diet used here. Body fat percentage may be crucial to this
metabolic subtype of OA, stimulating inﬂammatory changes due to
DIO that may differentiate a metabolic subtype from an LFD post-
traumatic OA model. The suggested subtype of Met-OA, and howit relates to OA onset, may be studied by using a high fat/high su-
crose DIO model with post-traumatic OA.
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